Mersana Therapeutics Stock Analysis

Mersana Stock Analysis Notes

About 95.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.6. Mersana Therapeutics had not issued any dividends in recent years. Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates for cancer patients with unmet need. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts. Mersana Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 169 people. To find out more about Mersana Therapeutics contact Martin MD at 617 498 0020 or learn more at https://www.mersana.com.

Mersana Therapeutics Investment Alerts

Mersana Therapeutics Upcoming and Recent Events

Mersana Largest EPS Surprises

View All Earnings Estimates

Mersana Therapeutics Environmental, Social, and Governance (ESG) Scores

Mersana Therapeutics Thematic Classifications

Mersana Stock Institutional Investors

Note, although Mersana Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Mersana Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 281.66 M.

Mersana Profitablity

The company has Profit Margin (PM) of (2.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.96) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.96.

Management Efficiency

Mersana Therapeutics has return on total asset (ROA) of (0.263) % which means that it has lost $0.263 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.1333) %, meaning that it created substantial loss on money invested by shareholders. Mersana Therapeutics' management efficiency ratios could be used to measure how well Mersana Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 2nd of December 2024, Return On Tangible Assets is likely to drop to -0.8. In addition to that, Return On Capital Employed is likely to drop to -1.11. At this time, Mersana Therapeutics' Other Current Assets are very stable compared to the past year. As of the 2nd of December 2024, Fixed Asset Turnover is likely to grow to 5.34, while Total Assets are likely to drop about 180.4 M.

Technical Drivers

As of the 2nd of December, Mersana Therapeutics secures the Mean Deviation of 4.84, downside deviation of 5.89, and Risk Adjusted Performance of 0.1079. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mersana Therapeutics, as well as the relationship between them.

Mersana Therapeutics Price Movement Analysis

Mersana Therapeutics Insider Trading Activities

Mersana Therapeutics Outstanding Bonds

Mersana Therapeutics Predictive Daily Indicators

Mersana Therapeutics Corporate Filings

Mersana Therapeutics Forecast Models

Mersana Therapeutics' time-series forecasting models are one of many Mersana Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mersana Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Mersana Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mersana shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mersana Therapeutics. By using and applying Mersana Stock analysis, traders can create a robust methodology for identifying Mersana entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mersana analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mersana analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Mersana Therapeutics stock analysis indicators help investors evaluate how Mersana Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mersana Therapeutics shares will generate the highest return on investment. By understating and applying Mersana Therapeutics stock analysis, traders can identify Mersana Therapeutics position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mersana Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Mersana Stock, please use our How to Invest in Mersana Therapeutics guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mersana Therapeutics. If investors know Mersana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mersana Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Mersana Therapeutics is measured differently than its book value, which is the value of Mersana that is recorded on the company's balance sheet. Investors also form their own opinion of Mersana Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Mersana Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mersana Therapeutics' market value can be influenced by many factors that don't directly affect Mersana Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mersana Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mersana Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mersana Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.